Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT00193518

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Tennessee Oncology, PLLC Nashville, Tennessee, United States

View Trial Details

Completed

Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma

NCT00193505

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Tennessee Oncology, PLLC Nashville, Tennessee, United States

View Trial Details

Completed

THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)

NCT01341262

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

AIDS and Cancer Specimen Bank (ACSB)

NCT00587912

Conditions: AIDS, AIDS-related Kaposi sarcoma, Acquired Immunodeficiency Syndrome, +28 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma

NCT00470405

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination

NCT00964210

Conditions: Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +43 more
Locations: Royal Childrens Hospital Melbourne, Victoria, Australia

View Trial Details

Completed

Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

NCT00101595

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +18 more
Locations: Local Institution Birmingham, Alabama, United States

Local Institution Anaheim, California, United States

Local Institution Los Angeles, California, United States

Local Institution Stanford, California, United States

View all 60 locations

View Trial Details

Completed

BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia

NCT00103701

Conditions: Blast Crisis, Bone Marrow Diseases, Bronchial Diseases, +32 more
Locations: Local Institution Los Angeles, California, United States

Local Institution Houston, Texas, United States

View Trial Details

Completed

VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL

NCT00274794

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: Cleveland Clinic Taussig Cancer Institute Cleveland, Ohio, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer

NCT00004105

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +39 more
Locations: NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions